Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2009 Jan;13(1):48-9.
doi: 10.4103/0972-124X.51896.

Staining of palatal torus secondary to long term minocycline therapy

Aravind Buddula  1
Affiliations
Case Reports

Staining of palatal torus secondary to long term minocycline therapy

Aravind Buddula. J Indian Soc Periodontol. 2009 Jan.

Abstract

Minocycline and other tetracycline analogs are well known to cause discoloring of alveolar bone, teeth and other tissues. The present case reports palatine torus discoloring, in a 91-year-old patient, after long term minocycline therapy. The patient was presented with staining of the palatal torus resulting from prior minocycline use for three-and-a-half years. The diagnosis of minocycline staining of palatal torus was done during a routine hygiene examination. The patient was informed that the bluish appearance of the palatal torus was the result of long term minocycline use. The patient was not willing to discontinue the antibiotic and was not concerned about the appearance. The clinician should inform patients on long term minocycline therapy about the possible side effects of staining of the alveolar bone, teeth and other soft tissue.

Keywords: Minocycline; palatal torus; staining.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

Figures

Figure 1
Figure 1
Staining of the palatal torus after minocycline therapy
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

  • Medication-Induced Oral Hyperpigmentation: A Systematic Review.
    Binmadi NO, Bawazir M, Alhindi N, Mawardi H, Mansour G, Alhamed S, Alfarabi S, Akeel S, Almazrooa S. Binmadi NO, et al. Patient Prefer Adherence. 2020 Oct 15;14:1961-1968. doi: 10.2147/PPA.S275783. eCollection 2020. Patient Prefer Adherence. 2020. PMID: 33116439 Free PMC article. Review.

References

    1. Freeman K. Therapeutic focus. Minocycline in the treatment of acne. Br J Clin Pract. 1989;43:112–5. - PubMed
    1. Eady EA, Cove JH, Holland KY, Cunliffe WJ. Superior antibacterial action and reduced incidence of bacterial resistance to minocycline compared to tetracycline-treated cane patients. Br J Dermatol. 1990;122:233–44. - PubMed
    1. Rebora A. The management of rosacea. Am J Clin Dermatol. 2002;3:489–96. - PubMed
    1. Piérard-Franchimont C, Goffin V, Arrese JE, Martalo O, Braham C, Slachmuylders P, et al. Lymecycline and minocycline in inflammatory acne: A randomized, double-blind intent-to-treat study on clinical and in vivo antibacterial efficacy. Skin Pharmacol Appl Skin Physiol. 2002;15:112–9. - PubMed
    1. Hoefnagel JJ, van Leeuwen RL, Mattie H, Bastiaens MT. Side effects of minocycline in the treatment of acne vulgaris. Ned Tijdschr Geneeskd. 1997;19:1424–7. - PubMed

Publication types